A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After Treatment — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(5 sites)
United States
Children's Hospital of Los Angeles (Data Collection Only), Los Angeles, California Children's Healthcare of Atlanta (Data Collection Only), Atlanta, Georgia Dana Farber Cancer Institute (Data Collection Only), Boston, Massachusetts Memorial Sloan Kettering Cancer Center, New York, New York Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio Last updated February 2026